You are here : Home > APPLIED RESEARCH > FACILITIES > Nano-biotechnology Platform

Articles & files | Files | Infrastructures | Health & life sciences | Nanomedicine | Nanosciences


Research Platform

Nano-biotechnology Platform

The 5,500 sq. m nano-biotechnology platform deploys a full range of medical systems development know-how from sample surface preparation, biological analysis and substrate functionalization to packaging, microfluidics, microsystems, biological detection systems and component readers.

Published on 27 February 2017

​R&D for biotechnology applications

The 5,500 sq. m nano-biotechnology platform deploys a full range of medical systems development know-how from sample surface preparation, biological analysis and substrate functionalization to packaging, microfluidics, microsystems, biological detection systems and component readers.

The platform’s R&D benefits scientific researchers, hospitals, and biomedical companies.

Its X-ray, gamma-ray, fluorescence, visible and lensless imaging solutions ensure its unmatched performance in studying living organisms, tissues, cells and bacteria.

Its microsystems meet today's new needs for personalized medicine, nanomedicine and remote diagnostics. They can be implemented in vivo, embedded or implanted in medical devices.

The platform is located next to Clinatec and the Bioscience and Biotechnology Institute of Grenoble (BIG) and leverages BIG’s basic research. The platform files around 35 patents per year including for solutions developed under R&D contracts with some 30 industrial partners.


KEY FIGURES:
  • 5,500 sq. m of facilities, including 2,500 sq. m of labs and clean rooms
  • €6 million in equipment
  • 200 employees
  • 35 patents filed per year
NOTABLE EQUIPMENT:
25 pieces of heavy equipment: X-ray measurement chambers, screen-printing machines, stamping and machining equipment, etc.


PARTNERS:
Around 30 industrial partners, including Fluoptics, Trixell, and Horiba

LOCATION:
Leti (Grenoble)